Your browser is no longer supported. Please, upgrade your browser.
Settings
AVXS AveXis, Inc. daily Stock Chart
AVXS [NASD]
AveXis, Inc.
Index- P/E- EPS (ttm)-4.93 Insider Own20.20% Shs Outstand32.53M Perf Week4.58%
Market Cap3.00B Forward P/E- EPS next Y-5.88 Insider Trans-0.16% Shs Float25.48M Perf Month-3.72%
Income-134.20M PEG- EPS next Q-1.47 Inst Own95.70% Short Float19.09% Perf Quarter18.03%
Sales- P/S- EPS this Y32.50% Inst Trans20.26% Short Ratio10.54 Perf Half Y22.58%
Book/sh15.78 P/B5.84 EPS next Y0.30% ROA-42.20% Target Price109.00 Perf Year116.73%
Cash/sh12.84 P/C7.18 EPS next 5Y9.25% ROE-45.60% 52W Range38.46 - 99.45 Perf YTD92.98%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-7.38% Beta-
Dividend %- Quick Ratio15.60 Sales past 5Y- Gross Margin- 52W Low139.50% ATR3.67
Employees70 Current Ratio15.60 Sales Q/Q- Oper. Margin- RSI (14)48.86 Volatility4.56% 3.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-203.70% Profit Margin- Rel Volume0.78 Prev Close96.14
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume461.25K Price92.11
Recom1.70 SMA20-1.02% SMA500.80% SMA20026.09% Volume360,473 Change-4.19%
Sep-15-17Initiated RBC Capital Mkts Sector Perform $92
Aug-29-17Initiated Instinet Reduce $52
Aug-23-17Initiated William Blair Outperform
Aug-17-17Initiated Evercore ISI Outperform $120
Aug-11-17Reiterated Chardan Capital Markets Buy $102.50 → $130
Aug-03-17Initiated Morgan Stanley Overweight
May-23-17Initiated Citigroup Buy $90
Mar-30-17Initiated UBS Buy $95
Nov-14-16Initiated Stifel Hold $65
Oct-21-16Initiated BofA/Merrill Buy
Aug-17-16Upgrade Wells Fargo Market Perform → Outperform
Aug-12-16Upgrade Jefferies Hold → Buy
Jul-15-16Initiated Wells Fargo Market Perform
Jun-22-16Downgrade Jefferies Buy → Hold
May-13-16Reiterated Goldman Buy $28 → $47
Mar-28-16Initiated Chardan Capital Markets Buy $60
Mar-07-16Initiated Jefferies Buy
Mar-07-16Initiated Goldman Buy
Sep-15-17 01:41PM  Edited Transcript of AVXS earnings conference call or presentation 10-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Sep-07-17 03:32PM  Breaking Down Barclays' New Bullish Calls On Biotech Benzinga
Aug-10-17 09:15PM  AveXis reports 2Q loss Associated Press
04:01PM  AveXis Reports Second Quarter 2017 Financial and Operating Results GlobeNewswire
Aug-09-17 07:30AM  [$$] Zinsli's Take: Biotech's Saviors Keep Up VCs' Hopes The Wall Street Journal
Aug-03-17 08:00AM  AveXis to Report Second Quarter 2017 Financial and Operating Results GlobeNewswire
Jul-18-17 08:42AM  AveXis Inc.: Buy at the High? Motley Fool
Jul-08-17 07:28AM  3 Stocks at All-Time Highs Still Worth Buying Motley Fool
Jul-01-17 11:41AM  4 Reasons the AveXis Inc. Rally Could Continue Motley Fool
Jun-26-17 04:00PM  AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Jun-22-17 11:03AM  3 Stocks You Probably Never Heard Of Could Catch Fire Soon TheStreet.com
08:35AM  AveXis (AVXS) Jumps: Stock Rises 7.1% Zacks
Jun-20-17 09:15PM  AveXis Announces Pricing of Public Offering of Common Stock GlobeNewswire
09:33AM  Biotech Movers: AveXis, Clovis, Epizyme TheStreet.com
Jun-19-17 04:00PM  AveXis Announces Proposed Public Offering of Common Stock GlobeNewswire
08:34AM  AveXis (AVXS) Surges: Stock Moves 5% Higher Zacks
Jun-14-17 04:00PM  AveXis Announces Alignment with FDA on GMP Commercial Manufacturing Process for AVXS-101 GlobeNewswire
Jun-07-17 04:01PM  REGENXBIO and AveXis Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector GlobeNewswire
04:00PM  AveXis and REGENXBIO Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector GlobeNewswire
May-31-17 12:01PM  Top Gainers in the Healthcare Sector: May 2226, 2017 Market Realist
May-18-17 08:38AM  What Falling Estimates & Price Mean for AveXis, Inc. (AVXS) Zacks
May-11-17 05:50PM  AveXis reports 1Q loss Associated Press
04:00PM  AveXis Reports First Quarter 2017 Financial and Operating Results GlobeNewswire
May-04-17 08:00AM  AveXis to Report First Quarter 2017 Financial and Operating Results GlobeNewswire
Apr-26-17 07:42AM  High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids TheStreet.com
Apr-25-17 10:33AM  AveXis Presents Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at the Annual Meeting of the American Academy of Neurology GlobeNewswire
Apr-18-17 08:00AM  AveXis to Host Webcast of Preclinical and Clinical Studies of AVXS-101 as Presented at the Annual Meeting of the American Academy of Neurology GlobeNewswire
Mar-30-17 04:08PM  Which Biotechs Are Buyable As Sector Recovers In 2017? Investor's Business Daily
04:08PM  Which Biotechs Are Buyable As Sector Recovers In 2017?
09:23AM  Coverage initiated on AveXis by UBS
Mar-23-17 01:04PM  AVEXIS, INC. Financials
Mar-22-17 03:10PM  Cytokinetics SMA Drug Did Well in Early Study Investopedia
03:10PM  Cytokinetics SMA Drug Did Well in Early Study at Investopedia
Mar-21-17 03:02PM  Billionaires' Best Healthcare Stock Picks of 2017 (So Far) Motley Fool -8.14%
03:02PM  Billionaires' Best Healthcare Stock Picks of 2017 (So Far) at Motley Fool
Mar-20-17 08:20AM  AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher Zacks -5.06%
Mar-17-17 11:44AM  AveXis Inc Stock Is Spiking Again Today -- Here's Why Motley Fool +15.42%
11:44AM  AveXis Inc Stock Is Spiking Again Today -- Here's Why at Motley Fool
11:03AM  AveXis, Esperion and Amgen Among Biotech Movers TheStreet.com
11:03AM  [video]AveXis, Esperion and Amgen Among Biotech Movers
10:25AM  AveXis Reports Positive Data for SMA Gene Therapy Investopedia
10:25AM  AveXis Reports Positive Data for SMA Gene Therapy at Investopedia
09:53AM  AveXis Offers Easily The Best Treatment Option For SMA Type-1 Patients Benzinga
09:15AM  Stock Futures Hold Gains; Adobe, Tiffany, Steel Dynamics Climb
06:57AM  Edited Transcript of AVXS earnings conference call or presentation 16-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
12:02AM  Futures Steady: 2 'A' Stocks Set To Soar, 1 Mule Ready To Kick
Mar-16-17 05:51PM  After-hours buzz: ADBE, AVXS, GOOS & more at CNBC
05:12PM  AveXis reports 4Q loss
04:30PM  AveXis Inc Earnings Call scheduled for 4:30 pm ET today
04:21PM  AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S
04:05PM  AveXis Reports Topline Results from Phase 1 Trial of AVXS-101 in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results GlobeNewswire
07:07AM  Q4 2016 AveXis Inc Earnings Release - After Market Close
Mar-14-17 02:05PM  5 Earnings Short-Squeeze Plays: Tiffany, Athene and More
Mar-09-17 08:15AM  Blog Coverage Heat Biologics Acquires Controlling Stake in Immuno-Oncology Company Pelican Therapeutics Accesswire
08:00AM  AveXis to Report Topline Phase 1 Trial Results in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results on March 16, 2017 GlobeNewswire
Mar-08-17 04:26PM  Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High
Mar-02-17 04:05PM  AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at AAN Annual Meeting GlobeNewswire
Feb-17-17 02:26PM  3 Stocks Setting Up for Major Breakouts
Feb-15-17 08:00AM  AveXis Appoints Rick Modi as Senior Vice President and Chief Business Officer GlobeNewswire
Feb-09-17 06:53PM  [$$] Venrock Refuels, and Goes Back on the Hunt at The Wall Street Journal
Feb-06-17 10:41AM  Chardan Analyst Suggests An AveXis-Ionis Pair Trade
08:27AM  AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  AveXis Announces Single-Arm Design for European Pivotal Study of AVXS-101 in SMA Type 1 Patients GlobeNewswire
Jan-31-17 08:00AM  AveXis Gene Therapy AVXS-101 Granted Access into EMA PRIME Program for Spinal Muscular Atrophy Type 1 GlobeNewswire +5.80%
Jan-13-17 02:35PM  Hurry! These 5 Stocks Are About to Break Out Explosively
Jan-09-17 09:16AM  AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-03-17 08:00AM  AveXis to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-30-16 02:23PM  Biotech's Top 3 Stock Losers, and Winners, in 2016 at Forbes
Dec-29-16 09:25AM  Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More at 24/7 Wall St.
Dec-27-16 07:45AM  Avexis Inc. (AVXS): RA Capital Management Ups Its Stake at Insider Monkey -5.93%
Dec-21-16 04:30PM  AveXis SMA Type 2 Call scheduled for 4:30 pm ET today
04:08PM  AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  AveXis to Use Intended Commercial GMP Product in SMA Type 2 Study GlobeNewswire
Dec-20-16 05:36PM  3 Reasons Biogen Inc. Stock Is Set to Soar in 2017 at Motley Fool
Dec-15-16 11:03AM  Citron Research On AveXis: This Will Be One Of 2017's Biotech Blowups
Dec-07-16 02:36AM  Do Hedge Funds Love ClubCorp Holdings Inc (MYCC)? at Insider Monkey
Dec-02-16 08:03AM  3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline at Motley Fool
Nov-10-16 05:02PM  AveXis reports 3Q loss
04:07PM  AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  AveXis Reports Third Quarter 2016 Financial and Operating Results GlobeNewswire
08:31AM  Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now
07:07AM  Q3 2016 AveXis Inc Earnings Release - After Market Close
Nov-09-16 10:36AM  Should You Sell AveXis (AVXS) Before Earnings?
08:10AM  Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC
Nov-08-16 08:19AM  Spinal Muscular Atrophy in Focus as Biogen, IONS Shoot Up on Data
08:00AM  AveXis to Present at Jefferies 2016 London Healthcare Conference GlobeNewswire
Nov-04-16 09:20AM  Can The Uptrend Continue for AveXis (AVXS)? +6.55%
Nov-03-16 12:09PM  AveXis Inc (AVXS): Of Course The FDA Didnt Ask For Placebo Data at Insider Monkey
Nov-02-16 01:41PM  Here's Why AveXis Shot Up 24.5% Today at Motley Fool +22.18%
Nov-01-16 04:10PM  AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  AveXis Announces Single-Arm Design for U.S. Pivotal Study of AVXS-101 in SMA Type 1 Patients GlobeNewswire
Oct-31-16 08:00AM  AveXis to Report Third Quarter 2016 Financial and Operating Results GlobeNewswire
Oct-17-16 02:27PM  If you want to know which way the market is heading, follow the leaders at MarketWatch
Oct-14-16 07:44AM  Is AveXis a Major Threat to Ionis Pharmaceuticals? at Motley Fool
Oct-11-16 04:32PM  AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
03:40PM  Biogen Gets Competition for SMA Therapy (BIIB) at Investopedia
Oct-10-16 07:00AM  AveXis to Host Webcast Update of Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 GlobeNewswire +5.41%
Oct-08-16 09:03AM  AveXis Reports Interim Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 as Presented at the International Annual Congress of the World Muscle Society Business Wire
Oct-07-16 04:55PM  Video Stock Market Analysis 10/7/16 +5.20%
Oct-03-16 11:19AM  A Few Recent IPOs that I am Watching
Early-stage biotech developing gene therapy for spinal muscular atrophy.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nagendran SukumarSr. VP & Chief Medical OfficerSep 01Option Exercise18.471,78032,8771,780Sep 05 05:22 PM
Nagendran SukumarSr. VP & Chief Medical OfficerSep 01Sale93.251,780165,9780Sep 05 05:22 PM
Nagendran SukumarSr. VP & Chief Medical OfficerAug 01Option Exercise18.471,78032,8771,780Aug 03 05:02 PM
Nagendran SukumarSr. VP & Chief Medical OfficerAug 01Sale91.521,780162,9060Aug 03 05:02 PM
Nagendran SukumarSr. VP & Chief Medical OfficerJul 03Option Exercise18.471,78032,8771,780Jul 05 06:05 PM
Nagendran SukumarSr. VP & Chief Medical OfficerJul 03Sale81.881,780145,7480Jul 05 06:05 PM
Nagendran SukumarSr. VP & Chief Medical OfficerJun 01Option Exercise18.471,78032,8771,780Jun 02 04:33 PM
Nagendran SukumarSr. VP & Chief Medical OfficerJun 01Sale70.911,780126,2140Jun 02 04:33 PM
Nagendran SukumarSr. VP & Chief Medical OfficerMay 01Option Exercise18.471,78032,8771,780May 02 04:59 PM
Nagendran SukumarSr. VP & Chief Medical OfficerMay 01Sale81.391,780144,8690May 02 04:59 PM
Nagendran SukumarSr. VP & Chief Medical OfficerApr 03Option Exercise18.471,78132,8951,781Apr 05 05:16 PM
Nagendran SukumarSr. VP & Chief Medical OfficerApr 03Sale76.131,781135,5880Apr 05 05:16 PM